20 March 2023
SHARE NOW
Cell Therapy
Gene Therapy
Logistics
Regulatory & Standards
Supply Chain
Viral/Non-Viral Vectors
Maggie Chen, Head of Manufacturing at AGC Biologics, explores the challenges within the cell and gene therapy landscape.
In this interview, Maggie initially considers challenges associated with the cost of goods and supply chain, before discussing how standardization will benefit viral vector development.
Maggie goes on to address analytics and bad data as rate limiting factors to the progression of the field, and how a combination of different approaches may be what’s needed to realize the future of cell and gene therapies, before explaining what we might have to look forward to from AGC Biologics.
This interview has been produced in partnership with AGC Biologics and was recorded at Advanced Therapies Week 2023.
 |
 |
More like this
ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies
We caught up with Patrick M Gailliot, Sr. Director, Patient Operations at Abeona Therapeutics, to talk to him about why his work gives him so much joy, preview his session at Advanced Therapies Week in Dallas, and explain the value he gets from the event.
26 November 2024
Texas Cell and Gene Manufacturing Landscape
Ahead of Advanced Therapies Week 2025 in Dallas, we take a look at the Texas cell and gene manufacturing landscape.
19 November 2024
Full Agenda Released for Advanced Therapies Week 2025 in Dallas
Phacilitate Unveils Full Agenda for Advanced Therapies Week 2025, Bringing Together Leaders to Shape the Future of Healthcare
12 November 2024
